scispace - formally typeset
B

Bernard Ducommun

Researcher at University of Toulouse

Publications -  158
Citations -  9562

Bernard Ducommun is an academic researcher from University of Toulouse. The author has contributed to research in topics: Cell cycle & Cdc25. The author has an hindex of 48, co-authored 158 publications receiving 9065 citations. Previous affiliations of Bernard Ducommun include Centre national de la recherche scientifique & Centre Hospitalier Universitaire de Toulouse.

Papers
More filters
Journal ArticleDOI

CDC25 phosphatases in cancer cells: key players? Good targets?

TL;DR: The roles of CDC25 phosphatases in both normal and abnormal cell proliferation are focused on, a critical assessment of the current data on CDC25 overexpression in cancer is provided, and both current and future therapeutic strategies for targeting CDC25 activity in cancer treatment are discussed.
Journal ArticleDOI

The when and wheres of CDC25 phosphatases.

TL;DR: Recent data demonstrate that in addition to the ATM/ATR-CHK pathway, a p38-MAPKAP pathway is also involved in controlling CDC25 activity during G(2)/M checkpoint activation and highlight the significance of developing specific CDC25 inhibitors for cancer therapy.
Journal ArticleDOI

p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

TL;DR: In this paper, the effects of p21/PCNA interaction on cell cycle progression were investigated using a tetracycline-regulated system, and it was shown that expression of wild-type p21 in p53-deficient DLD1 human colon cancer cells inhibits DNA synthesis and causes G1 and G2 cell cycle arrest.